ConductScience.org, home

Comparison · NCT00986245-b2163183

Once-daily of Ropinirole PR vs Twice-daily of Ropinirole PR: Patients Who Have Global Impression for Improvement to Duration of Motor Fluctuation

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Once-daily of Ropinirole PR vs Twice-daily of Ropinirole PR: Patients Who Have Global Impression for Improvement to Duration of Motor Fluctuation. Trial comparisons, record NCT00986245-b2163183. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00986245-b2163183

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.4430.3250.567wilson
Risk in group 20.6230.4970.734wilson
Risk difference, group 1 minus group 2-0.18-0.342-0.00368newcombe hybrid score
Risk ratio, group 1 over group 20.7110.5041log
Odds ratio, group 1 over group 20.4810.2330.991log
Number needed to treat, for one fewer participant with the outcome on Once-daily of Ropinirole PR than on Twice-daily of Ropinirole PR5.552.92272from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Once-daily of Ropinirole PROnce-daily regimen of Ropinirole PR administered in either first intervention peirod or second intervention period.2761OG000
Group 2Twice-daily of Ropinirole PRTwice-daily regimen of Ropinirole PR administered in either first intervention peirod or second intervention period.3861OG001

Outcome

Type
SECONDARY
Title
Patients Who Have Global Impression for Improvement to Duration of Motor Fluctuation
Description
Patients who have global impression for improvement to duration of motor fluctuation
Time frame
After 8 weeks in each arm or at last visit for early completion
Population
The number of patient who completed the study and answered the questionnaire for global impression to motor fluctuation duration.

Source ClinicalTrials.gov

Trial

Title
Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily
NCT number
NCT00986245
Phases
PHASE4
Conditions
Parkinson Disease
Interventions
Ropinirole Prolonged release
Lead sponsor
Seoul National University Hospital
Results first posted
2013-09-09

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00986245-b2163183